United Kingdom · Biopharma startup
United Kingdom · Touchlight Genetics
Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases.
Funding reportedLast round: Grant
Follow Touchlight Genetics and see its new rounds in your feed.Start following
What company datasets say Touchlight Genetics raised
Funding, as reported
Reported in all130.4Min the source's currency
Rounds10
Last roundGrant
Last round dateNov 2022
Investors listed5
Founders and team
From Touchlight Genetics's own website: 1 founder, 10 on the team.
- Karen FallenChief Executive Officer
- Bradley TheobaldGeneral Counsel & Chief of Staff
- Dr Jill MakinChief Scientific Officer
- Dr Tommy DuncanChief Business Officer
- David EdwardsNon-Executive Director
- David LewisNon-Executive Director
- Ingo EschweilerNon-Executive Director
- Leopoldo ZambelettiNon-Executive Director
- Thomas HardingNon-Executive Director
- Will DownieNon-Executive Director
On a portfolio page
Investors who name them
Each firm lists Touchlight Genetics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Touchlight Genetics in front of investors. Or tell us what we have wrong.